Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus-Reference-Cited by-同舟云学术

Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus

Published:2022-10 Issue:4 Volume:60 Page:106664
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

El Haj Cristina,Benavent Eva^ORCID,Sierra Yanik,Soldevila Laura,Rigo-Bonnin Raul^ORCID,Torrejón Benjamin,Gomez-Junyent Joan,Rosselló Irantzu,Murillo Oscar^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference36 articles.

1. The challenge of treating biofilm-associated bacterial infections;del Pozo;Clin Pharmacol Ther,2007

2. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America;Osmon;Clin Infect Dis,2013

3. European Medicines Agency (EMA). Xydalba summary of product characteristics 2015. https://ec.europa.eu/health/documents/community-register/2015/20150219130765/anx_130765_en.pdf.

4. Once-weekly dalbavancin versus daily conventional therapy for skin infection;Boucher;N Engl J Med,2014

5. Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16;Pfaller;J Antimicrob Chemother,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The MIC distribution of dalbavancin differs between different coagulase-negative staphylococci;JAC-Antimicrobial Resistance;2024-03-05

2. Antibiofilm approaches as a new paradigm for treating infections;Progress in Biomedical Engineering;2024-02-09

3. Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel;International Journal of Antimicrobial Agents;2023-11

4. In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement;Antibiotics;2023-09-13

5. Effective use of a two-dose regimen of dalbavancin to treat prosthetic joint infections and spinal hardware infections;European Journal of Orthopaedic Surgery & Traumatology;2023-06-04